This app was used in a “randomized, open-label, parallel-group comparative study (Phase III study) to evaluate the efficacy and safety of CA-NASH, a treatment app for non-alcoholic steatohepatitis (NASH).” This is a medical device program for the treatment of NASH. *This app is only available to some people who have participated in treatment. To use this service, you will need a prescription code issued by the investigator in charge.